A number of traditional medicine plants are hepatotoxic. Thus, while the traditional uses of Atuna racemosa suggest little indication for toxicity, it is nonetheless important to examine the potential for this extract to target the liver. Using Jurkat T cells and HepG2 hepatocytes as a model, the potential hepatotoxicity of this extract was evaluated. The results of a conditioned media experiment suggest that A. racemosa extract would likely be detoxified by the liver. These results provide the necessary background to Initiate an in vivo toxicology investigation.
BuenzEI.Country development does not presuppose the loss of forest resources for traditional medicine use. J Ethnopharmacol100:118-123, 2005.
2.
BuenzEI, SchneppleDJ, BauerBA, ElkinPL, RiddleIM, MotleyTJ.Techniques: bioprospecting historical herbal texts by hunting for new leads in old tomes. Trends Pharmacol Sci25:494-498, 2004.
3.
CoxPA.Will tribal knowledge survive the millennium? Science287:44-45, 2000.
4.
FeherM, SchmidtJM.Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci43:218-227, 2003.
5.
SchneppleDJ, BauerBA, BuenzEI.The future of phytopharmaceutical discovery. In: Teixeira da Silva J, Ed. Floriculture, Ornamental and Plant Biotechnology: Advances and Topical Issues. London: Global Science Books, pp370–372, 2006.
6.
BuenzEJ.Drug discovery from historic herbal texts. In: EkinsS, Ed. Computer Applications in Pharmaceutical Research and Development. Indianapolis: John Wiley & Sons, pp105–120, 2006.
7.
LeeRA, BalickMl, LingDL, SohlF, BrosiBJ, RaynorW.Special Report: Cultural Dynamism and Change—An Example from the Federated States of Micronesia. Econ Bot55:9-13, 2001.
8.
RiddleJM.History as a tool in identifying “new” old drugs. Adv Exp Med Biol505:89-94, 2002.
BuenzEJ, BauerBA, JohnsonHE, TavanaG, BeekmanEM, FrankKL, HoweCL.Historic herbal texts as a new paradigm for drug discovery. BMJ (London) (in press).
11.
RumphiusG.Herbarium Amboinense. Amsterdam: Johannes Burman, Book 1, Chapter 56, p4, 1741-1755.
12.
BalickMI, CoxPA.Plants, People, and Culture: The Science of Ethnobotany. New York: Scientific American Library, 1997.
13.
PranceG.The uses of Atuna racemosa Raf. (Chrysobalanaceae) in Samoa. Econ Bot58:470-475, 2004.
14.
NerurkarPV, DragullK, TangCS.In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones. Toxicol Sci79:106-111, 2004.
15.
GordonDW, RosenthalG, HartJ, SirotaR, BakerAL.Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA273:489-490, 1995.
16.
XuJ, MaM, PurcellWM.Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers. Toxicol Appl Pharmacol189:100-111, 2003.
17.
BuenzEJ, WeaverJG, BauerBA, ChalpinSD, BadleyAD.Cordyceps sinensis extracts do not prevent Fas-receptor and hydrogen peroxide-induced T-cell apoptosis. J Ethnopharmacol90:57-62, 2004.
18.
ShigenoM, NakaoK, IchikawaT, SuzukiK, KawakamiA, AbiruS, MiyazoeS, NakagawaY, IshikawaH, HamasakiK, NakataK, IshiiN, EguchiK.Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation. Oncogene22:1653-1662, 2003.
19.
RowinskyEK.Targeting the molecular target of rapamycin (mTOR), Curr Opin Oncol16:564-575, 2004.
20.
VezinaC, KudelskiA, SehgalSN.Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo)28:721-726, 1975.
21.
JacintoE, HallMN.Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol4:117-126, 2003.
22.
Mersch-SundermannV, KnasmullerS, WuXJ, DarroudiF, KassieF.Use of a human-derived liver cell line for the detection of cytoprotective, antigenotoxic and cogenotoxic agents. Toxicology198:329-340, 2004.
23.
YuR, MandlekarS, LeiW, FahlWE, TanTH, KongAT.p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J Biol Chem275:2322-2327, 2000.
24.
MariM, CederbaumAI.Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress. Hepatology33:652-661, 2001.
